Skip to main content
Premium Trial:

Request an Annual Quote

NCI Seeks Outside Information and Opinions about Biomarkers Programs

NEW YORK (GenomeWeb News) — The National Cancer Institute wants the scientific community to help it identify new priorities for biomarker discovery and validation research that could be conducted using resources of the Early Detection Research Network.

The information NCI receives may be used to help it identify future directions for the National Institutes of Health-funded EDRN, which is aimed at discovering, developing, and validating biomarkers for cancer risk assessment, early detection, and early diagnosis and prognosis. The network provides infrastructure and an environment that supports translational research by encouraging collaborations among basic scientists, population-based scientists, and clinically experienced scientists.

Now, NCI is seeking information from members of the scientific community, health professionals, biotech and pharmaceutical industries, and patient advocates.

The EDRN has four main components, including: Biomarker Developmental Laboratories focused on discovery, development, and characterization of new biomarkers; Biomarker Reference Laboratories that serve as a resource for clinical and lab validation of biomarkers; Clinical Epidemiology and Validation Centers that conduct early phases of clinical and epidemiological research on the application of biomarkers; and a Data Management and Coordinating Center that provides statistical, logistics, and informatics support, and develops the theoretical statistical approaches for biomarker analysis.

NCI is seeking information about promising research directions that could stimulate or accelerate biomarker development, and for transdisciplinary research collaborations. NCI also seeks information about strategies for developing or validating biomarkers, ideas about how the EDRN could partner with private industry and foundations, information about industry support, and funding and validation priorities.

More information about the request for information is available on NIH's website.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.